Male Breast Cancer and 5α-Reductase Inhibitors Finasteride and Dutasteride
November 2013
in “The Journal of Urology”
TLDR Using finasteride or dutasteride does not increase the risk of male breast cancer.
The study, which included 339 male breast cancer cases and 6,780 controls from a population of men aged 40-85 years in the United States between 2001-2009, found no significant association between the use of 5-alpha-reductase inhibitors (5ARIs), finasteride and dutasteride, and the risk of developing male breast cancer. Rate ratios (RR) for breast cancer with 5ARI exposure were not significant for various exposure assessment periods, including ≥1 year (RR 0.70), ≥2 years (RR 0.59), and ≥3 years (RR 0.75), as well as for each subsequent 180 days (RR 1.02) and 365 days (RR 1.03) of cumulative therapy. The study concluded that the risk of breast cancer should not affect the decision to prescribe 5ARI therapy for other conditions.
View this study on auajournals.org →
Cited in this study
research Efficacy and Safety of Finasteride Therapy for Androgenetic Alopecia
Finasteride helps hair growth but may cause sexual side effects.
research The Effect of Finasteride on the Risk of Acute Urinary Retention and the Need for Surgical Treatment among Men with Benign Prostatic Hyperplasia
Finasteride reduces urinary issues and surgery need in men with enlarged prostates by over 50%.
Related
research 5‐Alpha reductase inhibitors in androgenetic alopecia: Shifting paradigms, current concepts, comparative efficacy, and safety
Dutasteride works better than finasteride for hair loss, with both being safe to use.
research Luncheon Symposium (LS) : Update on the efficacy and safety of dutasteride in the management of androgenetic alopecia
Dutasteride is effective and safe for treating common hair loss, and it's more potent than finasteride, leading to better hair growth and thickness.
research Male Breast Cancer and 5α-Reductase Inhibitors Finasteride and Dutasteride
Using finasteride or dutasteride does not increase the risk of male breast cancer.
research The importance of dual 5α-reductase inhibition in the treatment of male pattern hair loss: Results of a randomized placebo-controlled study of dutasteride versus finasteride
Dutasteride more effective for hair growth, but has more side effects than finasteride.
research Pharmacogenetic analysis of human steroid 5α reductase type II: comparison of finasteride and dutasteride
Dutasteride is more efficient than finasteride, but individual results vary.
research A model for the turnover of dihydrotestosterone in the presence of the irreversible 5α-reductase inhibitors GI198745 and finasteride
Both drugs lower DHT levels, with GI198745 being more effective.